Skip to content

Active ingredient

Pyridostigmine

26 finished FDA listings contain Pyridostigmine as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
PYRIDOSTIGMINE BROMIDE
Dosage forms
Injection, Solution, Solution, Tablet, Tablet, Extended Release
Routes
Intravenous, Oral, Parenteral
Manufacturers / labelers
21
Strengths listed
105 mg/1 · 180 mg/1 · 30 mg/1 · 5 mg/ml · 60 mg/1 · 60 mg/5ml
Brand names in FDA listings
Mestinon, Pryidostigmine Bromide, Pyridostigmine, Regonol

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 9000

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 009829BAUSCH1955-04-061
NDA 011665BAUSCH1959-01-122
NDA 015193BAUSCH1965-01-251
NDA 017398SANDOZ1973-08-141
NDA 020414US ARMY2003-02-051
ANDA 040502IMPAX LABS2003-04-243
ANDA 040512ANI PHARMS2003-10-081
ANDA 205650ZYDUS PHARMS2015-06-224
ANDA 204737ALVOGEN2015-06-261
ANDA 205464RISING2017-08-151
ANDA 211181MLV2018-07-202
ANDA 211694NOVITIUM PHARMA2019-03-082
ANDA 208797RISING2020-01-092
ANDA 212702AMNEAL2020-01-101
ANDA 212405MILLA PHARMS2022-04-191
ANDA 216512MSN2023-09-211
NDA 217604AMNEAL2024-10-041

Official labeling on DailyMed

Showing the 12 most recent of 23 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.